IP Library Granted Patent US 11,344,726
Granted Patent B2
US 11,344,726 · App. 16/529,076 · Granted May 31, 2022

Systems and methods for the treatment of pain through neural fiber stimulation

Inventors: Maria E. Bennett (Beachwood, OH); Joseph W. Boggs (Chapel Hill, NC); Warren M. Grill (Chapel Hill, NC); John Chae (Strongsville, OH)
Assignee: SPR Therapeutics, Inc.
A61N1/36071A61N1/36003A61N1/36017A61N1/36021A61N1/36057
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,344,726
App. No.
16/529,076
Granted
May 31, 2022
Kind
B2
Abstract

Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.

Claims (22)

1. A method of reducing a perception of pain, the method comprising:

percutaneously inserting an electrode in-vivo a therapeutically effective distance from a target afferent nerve fiber; and

electrically stimulating through the electrode the target afferent nerve fiber at a frequency of about 4 kHz to about 20 kHz preventing stimulation-induced pain while generating a desired response in the target afferent nerve fiber to cause pain relief while avoiding generation of an unwanted response in a non-target nerve fiber.

2. The method of claim 1 , wherein electrically stimulating through the electrode the target afferent nerve fiber does not cause nerve damage or paresthesia.

3. The method of claim 1 , wherein the therapeutically effective distance is 1 mm.

4. The method of claim 1 , wherein the unwanted response in the non-target nerve fiber comprises painful muscle contraction or painful sensation.

5. A method of reducing a perception of pain, the method comprising:

percutaneously inserting an electrode in-vivo a therapeutically effective distance from a target afferent nerve fiber; and

electrically stimulating through the electrode the target afferent nerve fiber with a high frequency stimulation of about 4 kHz to about 20 kHz to generate a desired response in the target afferent nerve fiber while avoiding generation of unwanted responses in a non-target nerve fiber.

6. The method of claim 5 , wherein the desired response is pain relief.

7. The method of claim 5 , wherein the high frequency stimulation is a modulated high frequency stimulation.

8. The method of claim 7 , wherein electrically stimulating through the electrode the target afferent nerve fiber with a modulated high frequency stimulation does not produce nerve damage, pain, or paresthesia.

9. A method of claim 5 , wherein the therapeutically effective distance from a target afferent nerve fiber is 1 mm.

10. A method of reducing a perception of pain comprising:

applying high frequency electrical stimulation of about 4 kHz to about 20 kHz to at least a portion of a peripheral nervous system through an electrode inserted percutaneously and spaced at a distance at least 1 mm away from a targeted nerve structure to generate a stochastic response of action potentials in a plurality of target afferent sensory nerve fibers while avoiding action potentials in non-target small sensory afferent nerve fibers causing a reduction of perception of pain.

11. The method of claim 10 , wherein applying high frequency electrical stimulation does not produce nerve damage, pain, or paresthesia.

12. A system to reduce a perception of pain comprising:

an electrode percutaneously inserted in-vivo;

an electrical pulse generator applying electrical stimulation to at least a portion of a peripheral nervous system through the electrode at a frequency of about 4 kHz to about 20 kHz generating a desired response and preventing stimulation-induced pain in at least one target afferent sensory nerve fiber while avoiding action potentials in non-target small sensory afferent nerve fibers causing a reduction of perception of pain.

13. The system of claim 12 , wherein the high frequency electrical stimulation does not produce nerve damage, pain, or paresthesia.

14. The system of claim 12 , wherein the electrode is percutaneously inserted a therapeutically effective distance from the at least one target afferent sensory nerve fiber.

15. The system of claim 14 , wherein the therapeutically effective distance is 1 mm.

Assignments (3)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2022
From: BENNETT, MARIA E.; BOGGS, JOSEPH W., II; GRILL, WARREN M.; CHAE, JOHN
To: SPR THERAPEUTICS, INC.
Reel/Frame 058972/0226 →